Nuzenio

Obicetrapib

Obicetrapib news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

NewAmsterdam Pharma Wins CHMP Opinion for Obicetrapib Cholesterol Drug - The Clinical Trial VanguardThe Clinical Trial Vanguard · Thu, 06 Aug 2026 06:43:58 GMT Obicetrapib: The First Oral Drug To Move Amyloid AND Tau In APOE4 Carriers Jodie Whittaker (DZnYe58YOT) - MshaleMshale · Thu, 06 Aug 2026 00:03:46 GMT NAMS: Obicetrapib is set for global launch, backed by strong outcomes data and broad clinical differentiation - TradingViewTradingView · Wed, 05 Aug 2026 20:22:35 GMT NewAmsterdam reports $64.1M Q2 net loss, $678.3M cash; CHMP recommends obicetrapib approval - TradingViewTradingView · Wed, 05 Aug 2026 11:13:00 GMT NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 11:00:00 GMT CHMP backs first CETP inhibitor after two decades of failure - European Biotechnology MagazineEuropean Biotechnology Magazine · Wed, 29 Jul 2026 07:56:48 GMT

Timeline

Thu, 06 Aug 2026 06:43:58 GMTNewAmsterdam Pharma Wins CHMP Opinion for Obicetrapib Cholesterol Drug - The Clinical Trial Vanguard

Thu, 06 Aug 2026 00:03:46 GMTObicetrapib: The First Oral Drug To Move Amyloid AND Tau In APOE4 Carriers Jodie Whittaker (DZnYe58YOT) - Mshale

Wed, 05 Aug 2026 20:22:35 GMTNAMS: Obicetrapib is set for global launch, backed by strong outcomes data and broad clinical differentiation - TradingView

Wed, 05 Aug 2026 11:13:00 GMTNewAmsterdam reports $64.1M Q2 net loss, $678.3M cash; CHMP recommends obicetrapib approval - TradingView

Wed, 05 Aug 2026 11:00:00 GMTNewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results - GlobeNewswire

Wed, 29 Jul 2026 07:56:48 GMTCHMP backs first CETP inhibitor after two decades of failure - European Biotechnology Magazine

Related explainers

HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

CHMP4 live mentions European Biotechnology Magazine3 live mentions Obicetrapib Cholesterol Drug2 live mentions The Clinical Trial2 live mentions The First Oral2 live mentions Drug To Move2 live mentions Amyloid AND Tau2 live mentions Carriers Jodie Whittaker2 live mentions TradingView TradingView2 live mentions Reports Second Quarter2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Obicetrapib.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.